ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Of 105 cDNA samples derived from peripheral blood of CML patients carrying point mutations in the BCR-ABL1 TKD, 46 specimens including both individual and serial samples passed the initial quality control, and could therefore be subjected to quantitative comparison of subclone size assessment by different technical approaches.